Market Currents
The FDA approves Bristol-Myers' (BMY) anti-clotting drug Eliquis. The drug, which reduces the...
-
Friday, December 28, 2012, 4:32 PM ETThe FDA approves Bristol-Myers' (BMY) anti-clotting drug Eliquis. The drug, which reduces the risk of stroke and dangerous blood clots in patients with atrial fibrillation, is manufactured by BMY and co-marketed by Pfizer (PFE). Shares +1.7% AH.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
